Thermodynamic determination of the binding constants of angiotensin-converting enzyme inhibitors by a displacement method

FEBS Letters

Volumn 581, Issue 18, 2007, Pages 3449-3454

  Andújar Sánchez, Montserrat ^a   Jara Pérez, Vicente ^a   Cámara Artigas, Ana ^a  

^a UNIVERSITY OF ALMERÍA   (Spain)

Author keywords

Angiotensin I converting enzyme; Binding constants; Inhibitors; Isothermal titration calorimetry

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; LISINOPRIL;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CALORIMETRY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG BINDING; DRUG MECHANISM; DRUG STRUCTURE; NONHUMAN; PRIORITY JOURNAL; THERMODYNAMICS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BINDING SITES; CALORIMETRY; CRYSTALLOGRAPHY, X-RAY; DIPEPTIDES; HEAT; MODELS, MOLECULAR; PEPTIDYL-DIPEPTIDASE A; PROTEIN STRUCTURE, TERTIARY; THERMODYNAMICS; TITRIMETRY;

EID: 34447283577     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.06.048     Document Type: Article

References (35)

1. Skeggs L.T., Kahn J.R., and Shumway N.P. The preparation and function of the hypertensin-converting enzyme. J. Exp. Med. 103 (1956) 295-299
2. Smith C.G., and Vane J.R. The discovery of captopril. FASEB J. 17 (2003) 788-789
3. Patchett A.A., and Cordes E.H. The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin-converting enzyme. Adv. Enzymol. Relat. Areas Mol. Biol. 57 (1985) 1-84
4. Cushman D.W., and Ondetti M.A. Design of angiotensin converting enzyme inhibitors. Nat. Med. 5 (1999) 1110-1113
5. Soubrier F., Alhenc-Gelas F., Hubert C., Allegrini J., John M., Tregear G., and Corvol P. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc. Natl. Acad. Sci. USA 85 (1988) 9386-9390
6. Natesh R., Schwager S.L., Sturrock E.D., and Acharya K.R. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 421 (2003) 551-554
7. Natesh R., Schwager S.L., Evans H.R., Sturrock E.D., and Acharya K.R. Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry 43 (2004) 8718-8724
8. Corradi H.R., Schwager S.L., Nchinda A.T., Sturrock E.D., and Acharya K.R. Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design. J. Mol. Biol. 357 (2006) 964-974
9. Andujar-Sanchez M., Camara-Artigas A., and Jara-Perez V. A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme. Biophys. Chem. 111 (2004) 183-189
10. Binevski P.V., Sizova E.A., Pozdnev V.F., and Kost O.A. Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme. FEBS Lett. 550 (2003) 84-88
11. Guy J.L., Jackson R.M., Acharya K.R., Sturrock E.D., Hooper N.M., and Turner A.J. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence. Biochemistry 42 (2003) 13185-13192
12. Guy J.L., Jackson R.M., Jensen H.A., Hooper N.M., and Turner A.J. Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis. FEBS J. 272 (2005) 3512-3520
13. Leavitt S., and Freire E. Direct measurement of protein binding energetics by isothermal titration calorimetry. Curr. Opin. Struct. Biol. 11 (2001) 560-566
14. Velazquez Campoy A., and Freire E. ITC in the post-genomic era...? Priceless. Biophys. Chem. 115 (2005) 115-124
15. Wei L., Clauser E., Alhenc-Gelas F., and Corvol P. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J. Biol. Chem. 267 (1992) 13398-13405
16. Wiseman T., Williston S., Brandts J.F., and Lin L.N. Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal. Biochem. 179 (1989) 131-137
17. Sigurskjold B.W. Exact analysis of competition ligand binding by displacement isothermal titration calorimetry. Anal. Biochem. 277 (2000) 260-266
18. Andujar-Sanchez M., Camara-Artigas A., and Jara-Perez V. Purification of angiotensin I converting enzyme from pig lung using concanavalin-A sepharose chromatography. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 783 (2003) 247-252
19. Hubbard S.J., and Thornton J.M. 'NACCESS', Computer Program, Department of Biochemistry and Molecular Biology (1993), University College London
20. Spolar R.S., and Record Jr. M.T. Coupling of local folding to site-specific binding of proteins to DNA. Science 263 (1994) 777-784
21. Makhatadze G.I., and Privalov P.L. Energetics of protein structure. Adv. Protein Chem. 47 (1995) 307-425
22. Grobelny D., and Galardy R.E. A metabolite of aspartame inhibits angiotensin converting enzyme. Biochem. Biophys. Res. Commun. 128 (1985) 960-964
23. Galardy R.E. Inhibition of angiotensin converting enzyme by phosphoramidates and polyphosphates. Biochemistry 21 (1982) 5777-5781
24. Dunitz J.D. Win some, lose some: enthalpy-entropy compensation in weak intermolecular interactions. Chem. Biol. 2 (1995) 709-712
25. Skirgello O.E., Binevski P.V., Pozdnev V.F., and Kost O.A. Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme. Biochem. J. 391 (2005) 641-647
26. Wei L., Alhenc-Gelas F., Corvol P., and Clauser E. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J. Biol. Chem. 266 (1991) 9002-9008
27. Jaspard E., Wei L., and Alhenc-Gelas F. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. J. Biol. Chem. 268 (1993) 9496-9503
28. Cotton J., Hayashi M.A., Cuniasse P., Vazeux G., Ianzer D., De Camargo A.C., and Dive V. Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides. Biochemistry 41 (2002) 6065-6071
29. Bunning P., and Riordan J.F. Sulfate potentiation of the chloride activation of angiotensin converting enzyme. Biochemistry 26 (1987) 3374-3377
30. a values of pharmaceuticals by pressure-assisted capillary electrophoresis combined with short-end injection. J. Chromatogr. A 979 (2002) 369-377
31. Towler P., et al. ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J. Biol. Chem. 279 (2004) 17996-18007
32. Watermeyer J.M., Sewell B.T., Schwager S.L., Natesh R., Corradi H.R., Acharya K.R., and Sturrock E.D. Structure of testis ACE glycosylation mutants and evidence for conserved domain movement. Biochemistry 45 (2006) 12654-12663
33. Spolar R.S., Livingstone J.R., and Record Jr. M.T. Use of liquid hydrocarbon and amide transfer data to estimate contributions to thermodynamic functions of protein folding from the removal of nonpolar and polar surface from water. Biochemistry 31 (1992) 3947-3955
34. Ehlers M.R., and Riordan J.F. Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes. Biochemistry 30 (1991) 7118-7126
35. Woodman Z.L., Schwager S.L., Redelinghuys P., Carmona A.K., Ehlers M.R., and Sturrock E.D. The N domain of somatic angiotensin-converting enzyme negatively regulates ectodomain shedding and catalytic activity. Biochem. J. 389 (2005) 739-744